Your browser doesn't support javascript.
loading
Selective antibody intervention of Toll-like receptor 4 activation through Fc γ receptor tethering.
Shang, Limin; Daubeuf, Bruno; Triantafilou, Martha; Olden, Robin; Dépis, Fabien; Raby, Anne-Catherine; Herren, Suzanne; Dos Santos, Anaelle; Malinge, Pauline; Dunn-Siegrist, Irene; Benmkaddem, Sanae; Geinoz, Antoine; Magistrelli, Giovanni; Rousseau, François; Buatois, Vanessa; Salgado-Pires, Susana; Reith, Walter; Monteiro, Renato; Pugin, Jérôme; Leger, Olivier; Ferlin, Walter; Kosco-Vilbois, Marie; Triantafilou, Kathy; Elson, Greg.
Afiliação
  • Shang L; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland, lshang@novimmune.com.
  • Daubeuf B; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Triantafilou M; the Cardiff University School of Medicine, Department of Child Health, University Hospital of Wales, Cardiff, United Kingdom.
  • Olden R; the Cardiff University School of Medicine, Department of Child Health, University Hospital of Wales, Cardiff, United Kingdom.
  • Dépis F; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Raby AC; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Herren S; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Dos Santos A; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Malinge P; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Dunn-Siegrist I; the University Hospitals of Geneva, 1211 Geneva, Switzerland.
  • Benmkaddem S; INSERM UMR 699, Faculté de Médecine Paris Diderot, Site Xavier Bichat, 16 Rue Henri Huchard, Paris 75018 Cedex 18, France, and.
  • Geinoz A; the Department of Pathology and Immunology, University of Geneva Medical School, Geneva 1211, Switzerland.
  • Magistrelli G; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Rousseau F; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Buatois V; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Salgado-Pires S; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Reith W; the Department of Pathology and Immunology, University of Geneva Medical School, Geneva 1211, Switzerland.
  • Monteiro R; INSERM UMR 699, Faculté de Médecine Paris Diderot, Site Xavier Bichat, 16 Rue Henri Huchard, Paris 75018 Cedex 18, France, and.
  • Pugin J; the University Hospitals of Geneva, 1211 Geneva, Switzerland.
  • Leger O; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Ferlin W; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Kosco-Vilbois M; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
  • Triantafilou K; the Cardiff University School of Medicine, Department of Child Health, University Hospital of Wales, Cardiff, United Kingdom.
  • Elson G; From the NovImmune SA, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland.
J Biol Chem ; 289(22): 15309-18, 2014 May 30.
Article em En | MEDLINE | ID: mdl-24737331
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de IgG / Receptor 4 Toll-Like / Inflamação / Macrófagos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de IgG / Receptor 4 Toll-Like / Inflamação / Macrófagos Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article